Fight against pharma counterfeiting must go deeper: TruTag A leader from the anti-counterfeit solutions firm says that while packaging-level efforts may have an effect, on-dose technology is worth a closer look.
Pharmaceutical counterfeiting is a serious, pervasive threat; according to the World Health Organization, fake drugs drain the global economy of as much as $200b in lost profits annually. Considering the risk to patient safety, it is an issue with potentially deadly consequences.
Michael Bartholomeusz, TruTag CEO, told Outsourcing-Pharma that the pharmaceutical industry is highly focused on finding ways to defeat counterfeiters.
“
Pharmaceutical companies and the industry at large are acutely aware of the problem of counterfeit and diversion and have expended enormous effort, resources and money around grappling with the problem,” he said. “